Endoscopic therapy for Barrett's esophagus.
With the increase in the rate of esophageal adenocarcinoma in the United States and the Western world matched with the high morbidity and mortality of esophagectomy, there is an increasing need for new and effective techniques to treat and prevent esophageal adenocarcinoma. A wide variety of endoscopic mucosal ablative techniques have been developed for early esophageal neoplasia. However, long-term control of neoplasic risk has not been demonstrated. Most studies show that specialized intestinal metaplasia may persist underneath neo-squamous mucosa, posing a risk for subsequent neoplastic progression. In this article we review current published literature on endoscopic therapies for the management of Barrett's esophagus.
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Alway Building M-211, CA 94305, USA. yehr@stanford.edu
Ronald W
RW
Yeh
George
G
Triadafilopoulos
D001471:Barrett Esophagus / Q000473:pathology / Q000628:therapy*; D001706:Biopsy; D017115:Catheter Ablation; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D016629:Esophagectomy; D006801:Humans; D010778:Photochemotherapy